Dates of 2025 Scientific Advice Working Party (SAWP) meetings and submission deadlines scientific advice, protocol assistance, qualification of biomarkers and EMA/EUnetHTA parallel consultation requests

EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna

Presentation - International collaboration to facilitate medicines availability global assessment / inspection pathways

Presentation - Update on Network Portfolio activities

Presentation - Revised CTIS transparency rules and new version of the public portal

Presentation - Update on the development of the European Shortages Monitoring Platform (ESMP)

EMA’s safety committee elects new chair

Timetable: Initial (full) marketing authorisation application accelerated assessment timetables

Timetable: Initial (Full) marketing authorisation application - ATMP

Annual activity report 2023